Pulmonary embolisms usually travel to a deep vein in the leg. To treat a pulmonary embolism (PE), which occurs when a blood clot gets caught in an artery that travels from the heart to the lungs.To treat deep vein thrombosis (DVT), which occurs when a blood clot forms in one or more of the body’s deep veins.To reduce the risk of blood clots and stroke in individuals with atrial fibrillation that was not caused by a heart valve problem.Doctors prescribe Xarelto® for the following reasons and more: Blood thinners like Xarelto® are prescribed to help prevent these types of dangerous conditions. Blood clots can also create significant risk, however, potentially causing catastrophic health problems. Coagulation prevents dangerously excessive blood loss when there is a cut or internal bleeding. An essential component of healing is coagulation, which is thickening or clotting of the blood. ![]() Xarelto®, which is Rivaroxaban in the generic form, is an anticoagulant or blood thinner. They can also help plaintiffs determine the types of legal arguments juries may be inclined to respond to. Such trials often set precedent and help others anticipate how future trials may turn out. A bellwether trial involves a small consolidation of lawsuits taken from a larger group of cases to be tried first. Prior to the Hartman case, there were three bellwether trials in federal courts in which the defense in the Xarelto® lawsuits won. The compensation the jury awarded to Hartman included $1.8 million in compensatory damages and $26 million in punitive damages. A doctor had prescribed Xarelto® for Hartman in treatment of atrial fibrillation and other health problems. On December 5, 2017, a jury in a state court ordered the two mega-pharmaceuticals to pay plaintiff Lynn Hartman nearly $28 million due to complications such as internal bleeding that she experienced as a result of using Xarelto®. Though the FDA has said that Xarelto® is associated with as many as 400 deaths, the government agency has not recalled the anticoagulant. The more than 13 million prescriptions of Xarelto® filled since the drug’s release have generated billions of dollars for Johnson & Johnson and Bayer. Drugmakers Johnson & Johnson and Bayer are the companies being sued on claims that knowledge about risks of significant bleeding were consciously concealed for the purpose of boosting sales. Xarelto® is the nation’s most-prescribed blood thinner in its class. ![]() Food and Drug Administration (FDA) in 2011. Xarelto Lawsuits: Outside the courtroomīetween federal and state courts, more than 20,000 Xarelto® lawsuits have been filed since the blockbuster drug was approved by the U.S.Thousands of IVC Filter Lawsuits Pending While Patients Suffer Fatal Complications.BREAKING NEWS: Conservative Arizona jurors find in favor of manufacturer bard as plaintiff watches in tears. ![]() Hernia Mesh, how a patch can torment your body after surgery.Smith & Nephew’s Knee Replacement Device Recalled.October 2018 XARELTO® Lable Change: TOO LITTLE, TOO LATE AND RECKLESSLY MISLEADING.This Bone Cement May Risk Your Knee, But The Usage Increases Steadily.Misleading marketing of Pradaxa® causes deaths, attorneys fight for patient redress.Bayer’s Monsanto Roundup Weed Killer Linked to Cancer, Facing 9,000+ Lawsuits.3M Sells Defective Earplugs to the US Military, Pays $9.1 Million Settlement.Johnson & Johnson Facing 1000’s of Lawsuits over Asbestos in Talcum Powder Products.AstraZenecas Under Fire For Heart Failure Cases Related to Diabetes Drug Onglyza.Takeda’s Uloric For Gout Found to Cause Cardiovascular-Related Death in Patients.Bayer In Trouble Again as Essure Sterilization Device Lawsuits Exceed 18,000.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |